We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FFIV:NASDAQF5, Inc. Analysis

Data as of 2026-05-28 - not real-time

$383.43

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

F5, Inc. is trading well above its short‑ and medium‑term moving averages, confirming a strong bullish trend supported by a bullish MACD histogram and an RSI that sits in the upper range. Recent earnings beat expectations, with revenue expanding at a double‑digit pace and margins remaining exceptionally high, reinforcing the company’s high‑profitability profile. The stock is approaching its recent high and encounters notable resistance, while volume has stayed stable, suggesting that short‑term momentum may be tempering.
Valuation appears mixed: the price‑to‑earnings multiple is comfortably below the sector average, yet a discounted cash‑flow model points to a modest downside relative to the current price. The absence of a dividend underscores the growth‑oriented nature of the business, and the balance sheet shows ample cash and modest net debt, supporting continued investment in strategic partnerships and AI‑driven product cycles.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical resistance and overbought conditions
  • Strong recent earnings beat but limited upside on the near term
  • Stable volume and bullish trend may support a pause rather than a rally

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustained double‑digit revenue growth and high profit margins
  • Strategic partnership expanding addressable market in agentic commerce
  • Valuation gap between industry peers and current multiple offering upside

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Durable high‑margin software and services business with recurring revenue
  • AI‑driven hardware refresh cycle positioning the company for future growth
  • Strong cash generation and modest leverage supporting long‑term investments

Key Metrics & Analysis

Financial Health

Revenue Growth11.00%
Profit Margin21.96%
P/E Ratio31.5
ROE20.34%
ROA8.15%
Debt/Equity7.12
P/B Ratio6.2
Op. Cash Flow$1.0B
Free Cash Flow$759.2M
Industry P/E40.9

Technical Analysis

TrendBullish
RSI69.0
Support$318.93
Resistance$399.59
MA 20$362.32
MA 50$324.27
MA 200$293.49
MACDBullish
VolumeStable
Fear & Greed Index93.32

Valuation

Fair Value$302.81
Target Price$373.90
Upside/Downside-2.49%
GradeFair
TypeGrowth

Risk Assessment

Beta1.01
Volatility34.91%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.